Clinic
South Texas Family Planning & Health Corporation
South Texas Family Planning & Health Corporation was paid $1.32M by Medicaid between Feb 2018 and Dec 2024, across 37 billing codes. Its largest line is S4993, Contraceptive pills for birth control — 19% of everything it billed.
33Billing provider infoSOUTH TEXAS FAMILY PLANNING & HEALTH CORPORATION
CORPUS CHRISTI, TX 78411
CORPUS CHRISTI, TX 78411
33aNPI1760535660assigned 01/22/2007
33bProvider typeAmbulatory Family Planning Facility
28Total paid$1.32M
24GClaims67,352
24DCodes billed37
24AFirst – last monthFeb 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Family Planning Facility providers in Texas
Rank by total paid#5 of 73
Median peer was paid$144K
This provider vs. median9.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 97 | $931.26 | |
| 2019 | 110 | $1K | |
| 2020 | 11,887 | $247K | |
| 2021 | 17,701 | $386K | |
| 2022 | 19,219 | $371K | |
| 2023 | 15,438 | $283K | |
| 2024incomplete | 2,900 | $35K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S4993 | Contraceptive pills for birth control | 19% | 2,582 | 2,503 | $258K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 8,044 | 7,351 | $213K |
| A4267 | Contraceptive supply, condom, male, each | 14% | 16,026 | 14,414 | $184K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 12% | 2,551 | 2,513 | $158K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 10% | 1,994 | 1,971 | $137K |
| 99385 | 4.0% | 883 | 846 | $54K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 3.0% | 83 | 79 | $39K |
| 81025 | 2.5% | 4,916 | 4,646 | $33K | |
| 80061 | Lipid panel | 2.3% | 4,354 | 4,242 | $31K |
| A9150 | Non-prescription drugs | 2.3% | 1,808 | 1,719 | $30K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.0% | 4,573 | 4,469 | $27K |
| J7295 | Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each | 1.8% | 25 | 25 | $24K |
25 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 2,093 | $23K |
| G0433 | Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening | 1.5% | 1,448 | $20K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 1.4% | 30 | $19K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 885 | $16K |
| G0475 | Hiv antigen/antibody, combination assay, screening | 1.1% | 673 | $14K |
| 82947 | <1% | 4,138 | $8K | |
| 81003 | <1% | 3,167 | $6K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 193 | $5K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 193 | $5K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 74 | $4K |
| 85018 | <1% | 2,399 | $4K | |
| 85014 | <1% | 1,918 | $4K | |
| 11982 | <1% | 25 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 42 | $1K |
| 87210 | <1% | 249 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 33 | $880.61 |
| 0011A | <1% | 25 | $824.00 | |
| 99000 | <1% | 86 | $811.08 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 136 | $535.11 |
| 90688 | <1% | 12 | $201.72 | |
| 88142 | <1% | 12 | $170.20 | |
| J3490 | Unclassified drugs | 0% | 1,628 | $0.00 |
| 91301 | 0% | 28 | $0.00 | |
| H1010 | Non-medical family planning education, per session | 0% | 12 | $0.00 |
| 90734 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZUNIGA, MARTHA (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| South Texas Family Planning & Health Corporation | Beeville, TX | $745K |
| South Texas Family Planning & Health Corporation | Kingsville, TX | $593K |
| South Texas Family Planning & Health Corporation | Sinton, TX | $379K |
| South Texas Family Planning & Health Corporation | Rockport, TX | $307K |
| South Texas Family Planning & Health Corporation | Robstown, TX | $137K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.